"The idea is that transparency will encourage doctors to evaluate whether these are appropriate relationships with companies or not," Daniel Carlat, a psychiatrist and director of the prescription project at the Pew Charitable Trusts, told The Journal.
I'm sorry for laughing out loud at this...